Gilead Reports Positive Results for Lenacapavir, Semiannual HIV Treatment
August 1st 2021The favorable results could mean a new treatment option for patients with HIV whose disease has not responded to other treatments. They may also be another step toward HIV treatment that doesn’t depend on daily pills.
Read More